AseBio welcomes the designation of CNCps as a Notified Body for Certifying In Vitro Diagno... 20/02/2025 Healthcare Access to innovation Innovative drugs We trust that this decision will help reduce the bottleneck caused by the high demand for certification under the new... AseBio
AseBio welcomes the designation of CNCps as a Notified Body for Certifying In Vitro Diagno... 20/02/2025 It joins the other 13 European entities authorized to assess the compliance of these products before they reach the... AseBio
ZYMVOL raises €3 million in seed funding 20/02/2025 Healthcare Innovative drugs Financing Partners - Zymvol Biomodeling
Repsol invests in DARWIN and transfers an innovative biotechnology solutio 20/02/2025 Healthcare Innovative drugs Talento Repsol, through its investment arm Repsol Corporate Venturing, has acquired a 21.43% stake in DARWIN Bioprospecting... Partners
ORYZON announces journal publication of final Phase IIa REIMAGINE results with vafidemstat... 14/02/2025 Healthcare Innovative drugs The Phase IIa study REIMAGINE evaluated the safety and preliminary efficacy of vafidemstat in agitation/aggression in... Partners - Oryzon Genomics
EIB finances with €15 million Amadix to develop innovative diagnostic tests for early canc... 11/02/2025 Healthcare Innovative drugs Advanced therapies EU projects Financing Amadix is a Spanish biotech company developing non-invasive blood tests for early detection of several types of cancer... Partners - Amadix
Vaccines, gene-editing-based therapies, and immunotherapies will transform the current lan... 04/02/2025 Healthcare Access to innovation Drug discovery Innovative drugs Personalized medicine Advanced therapies Biotechnology has radically changed the treatment of many types of tumors, evolving from highly aggressive and non... AseBio - BATEA ONCOLOGY S.L.
Vaccines, gene-editing-based therapies, and immunotherapies will transform the current lan... 04/02/2025 BATEA ONCOLOGY S.L. It will also be necessary to develop therapies with fewer side effects, allowing the combination of different treatments... AseBio - BATEA ONCOLOGY S.L.
Pharmacovigilance training VI edition, Barcelona & Online 12-13 May 2025 30/01/2025 Healthcare Innovative drugs Partners - PVpharm
ORYZON announces first patient dosed in an Investigator-initiated Phase I study of iadadem... 23/01/2025 Healthcare Innovative drugs Study led by Medical College of Wisconsin and exploring the combination with azacitidine. Partners - Oryzon Genomics
